You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

vinorelbine

Showing 1 - 25 of 172
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Inetetamab Combined With Pyrotinib and Vinorelbine as First-line

Recruiting
  • Breast Neoplasms
  • Nanjing, Jiangsu, China
    Jiangsu Provincial People's Hospital
Mar 16, 2023

Anaplastic Large Cell Lymphoma, Vinorelbine Trial in Shanghai (Vinorelbine)

Completed
  • Anaplastic Large Cell Lymphoma
  • Vinorelbine
  • Vinorelbine
  • Shanghai, Shanghai, China
    Shanghai Children's Medical Center
Jul 23, 2022

Non Small Cell Lung Cancer (NSCLC), Malignant Pleural Mesothelioma (MPM) Trial in Marseille (Vinorelbine)

Completed
  • Non Small Cell Lung Cancer (NSCLC)
  • Malignant Pleural Mesothelioma (MPM)
  • Vinorelbine
  • Marseille, France
    Assistance Publique des Hôpitaux de Marseille (CEPCM)
Nov 15, 2022

Breast Carcinoma, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Chicago

Not yet recruiting
  • Breast Carcinoma
  • +2 more
  • Biospecimen Collection
  • +6 more
  • Chicago, Illinois
    Northwestern University
Nov 14, 2023

NSCLC, Carcinoma Breast Trial in Suzhou (Vinorelbine, Radiotherapy, PD-1/PD-L1 inhibitor)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma Breast
  • Vinorelbine
  • +4 more
  • Suzhou, China
    Second Affiliated Hospital of Soochow University
Oct 29, 2022

Rhabdomyosarcoma Trial in Los Angeles (Vinorelbine, Mocetinostat)

Recruiting
  • Rhabdomyosarcoma
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 13, 2022

HER2-positive Advanced Breast Cancer Trial in Tianjin (Pyrotinib Maleate, Vinorelbine)

Completed
  • HER2-positive Advanced Breast Cancer
  • Pyrotinib Maleate
  • Vinorelbine
  • Tianjin, China
    Tianjin Cancer Hospital
Apr 6, 2022

HER2-positive Metastatic Breast Cancer, Locally Advanced HER2 Positive Breast Carcinoma Trial in Spain (Tucatinib, Trastuzumab,

Not yet recruiting
  • HER2-positive Metastatic Breast Cancer
  • Locally Advanced HER2 Positive Breast Carcinoma
  • Cádiz, Andalucía, Spain
  • +17 more
Jan 16, 2023

Tumors, Child, Adolescent Trial in Leiden (Ramucirumab, Cyclophosphamide, Vinorelbine)

Recruiting
  • Neoplasms
  • +2 more
  • Leiden, Netherlands
    Leids Universitair Medisch Centrum
Aug 14, 2023

Metastatic Breast Cancer Trial (SKB264, Eribulin, Capecitabine)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Oct 7, 2023

Non Hodgkin Lymphoma Trial (Liposomal Mitoxantrone Hydrochloride dose level 1, Liposomal Mitoxantrone Hydrochloride dose level

Not yet recruiting
  • Non Hodgkin Lymphoma
  • Liposomal Mitoxantrone Hydrochloride dose level 1
  • +6 more
  • (no location specified)
Mar 17, 2022

Mesothelioma Trial in Cardiff (Vinorelbine, Active Symptom Control)

Completed
  • Mesothelioma
  • Vinorelbine
  • Active Symptom Control
  • Cardiff, United Kingdom
    Wales Cancer Trials Unit
Oct 4, 2021

Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

Not yet recruiting
  • Rhabdomyosarcoma
  • Palo Alto, California
  • +2 more
Aug 27, 2023

HER2-negative Breast Cancer, Advanced Breast Cancer Trial in Guangzhou (Organoid-guided treatment, Taxane, Capecitabine)

Not yet recruiting
  • HER2-negative Breast Cancer
  • Advanced Breast Cancer
  • Organoid-guided treatment
  • +5 more
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Oct 22, 2023

Anaplastic Large Cell Lymphoma, Vinorelbine Trial in Shanghai (Vinorelbine)

Recruiting
  • Anaplastic Large Cell Lymphoma
  • Vinorelbine
  • Vinorelbine
  • Shanghai, Shanghai, China
    Shanghai Children's Medical Center
Jul 28, 2021

NSCLC Trial in France (Atezolizumab, Vinorelbine)

Completed
  • Non-small Cell Lung Cancer
  • Aix-en-Provence, France
  • +12 more
May 11, 2022

Advanced Cancer, Metastatic Cervical Cancer Trial in Albuquerque, Yerevan (Balstilimab (BAL), Topotecan, Vinorelbine)

Withdrawn
  • Advanced Cancer
  • Metastatic Cervical Cancer
  • Balstilimab (BAL)
  • +5 more
  • Albuquerque, New Mexico
  • +2 more
Oct 3, 2022

Metastatic Breast Cancer Trial (Pyrotinib, Vinorelbine, Inetetamab)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Jul 11, 2021

Metastatic Breast Cancer Trial in Shanghai (Vinorelbine, DDP)

Recruiting
  • Metastatic Breast Cancer
  • Shanghai, China
    Fudan University Cancer Hospital
Apr 19, 2022

Breast Cancer Trial in Italy (Paclitaxel, Cyclophosphamide, Capecitabine)

Active, not recruiting
  • Breast Cancer
  • Aviano, Italy
  • +19 more
Aug 31, 2022

Standard Anti-microtubule Drugs as Assessed by Early Tumor

Recruiting
  • Breast Cancer
  • Breast Neoplasms
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Dec 10, 2021

Metastatic Breast Cancer Trial in Napoli (vinorelbine, carboplatin, trastuzumab)

Active, not recruiting
  • Metastatic Breast Cancer
  • vinorelbine
  • +2 more
  • Napoli, Italy
    Istituto Nazionale dei Tumori, Divisione di Oncologia Medica C
Mar 3, 2021

Breast Cancer Metastatic Trial in Worldwide (MCLA-128, Trastuzumab, Vinorelbine)

Active, not recruiting
  • Breast Cancer Metastatic
  • Los Angeles, California
  • +24 more
Aug 10, 2022

Triple Negative Breast Cancer Trial in Shanghai (Personalized treatment guided by mini-PDX and RNA sequencing, Nab paclitaxel,

Recruiting
  • Triple Negative Breast Cancer
  • Personalized treatment guided by mini-PDX and RNA sequencing
  • +5 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 18, 2022

Metastatic Triple Negative Breast Cancer Trial (pembrolizumab, capecitabine, eribulin)

Completed
Has Results
  • Metastatic Triple Negative Breast Cancer
  • pembrolizumab
  • +4 more
  • (no location specified)
Nov 9, 2021